Norris Medicines Ltd — Insider Trading, 24-06-2026: Insider Trading / SAST

Norris Medicines has closed its trading window for Designated Persons, including promoters, directors, and their immediate relatives, effective 1st July, 2026. This action aligns with the company's insider trading policy to prevent unfair trading. The window will reopen 48 hours after the financial results for the quarter are publicly declared. The company will announce the specific date for the board meeting to approve these results in due course. This ensures compliance and maintains market integrity for shareholders.